4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000025
CEO bought 55,000 shares at an average $0.01 ($646)
- CEO bought 2,000 shares at $0.01 ($27)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-25 | Purchase : show line 1 in the form | −2,000 | $0.01 | $27 | 21,061,123 | D |
| 2019-04-25 | Purchase : show line 2 in the form | +2,000 | $0.01 | $23 | 21,063,123 | D |
| 2019-04-25 | Purchase : show line 3 in the form | +10,000 | $0.01 | $117 | 21,073,123 | D |
| 2019-04-25 | Purchase : show line 4 in the form | +5,000 | $0.01 | $61 | 21,078,123 | D |
| 2019-04-25 | Purchase : show line 5 in the form | +2,000 | $0.01 | $25 | 21,080,123 | D |
| 2019-04-25 | Purchase : show line 6 in the form | +5,000 | $0.01 | $62 | 21,085,123 | D |
| 2019-04-25 | Purchase : show line 7 in the form | +2,000 | $0.01 | $24 | 21,087,123 | D |
| 2019-04-25 | Purchase : show line 8 in the form | +2,000 | $0.01 | $23 | 21,089,123 | D |
| Open-market purchases · 57,000 sh · avg $0.01 · $673 | ||||||
Loading xslF345X03/primary_doc.xml…